Insider Trading History of Rosenberg Martin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Rosenberg Martin since 2008. The trader's CIK number is 1320122. At the time of the last reporting, Rosenberg Martin was the Director of Cubist Pharmaceuticals Inc. (stock ticker symbol CBST). Also see all insider trading activities at Cubist Pharmaceuticals Inc.


Yearly summary of insider trading at Cubist Pharmaceuticals Inc (CBST) by Rosenberg Martin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 CBST 0 $0 15,472 $1,005,680 16,819 $368,388
2012 CBST 0 $0 40,000 $1,684,660 40,000 $650,550
2011 CBST 0 $0 11,500 $426,661 11,500 $209,530
2009 CBST 0 $0 0 $0 2,000 $19,120
2008 CBST 0 $0 10,000 $220,000 10,000 $100,200


Insider trading of Cubist Pharmaceuticals Inc (CBST) by Rosenberg Martin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-09-09 CBST Option Ex 15,472 23.81 368,388
2013-09-09 CBST Sale 15,472 65.00 1,005,680
2013-06-06 CBST Option Ex 1,347 .00 0
2012-10-01 CBST Option Ex 10,000 22.71 227,100
2012-10-01 CBST Sale 10,000 47.75 477,480
2012-07-02 CBST Sale 10,000 37.88 378,760
2012-07-02 CBST Option Ex 10,000 22.30 222,950
2012-04-02 CBST Option Ex 10,000 .00 0
2012-04-02 CBST Sale 10,000 42.76 427,600
2012-01-03 CBST Option Ex 10,000 20.05 200,500
2012-01-03 CBST Sale 10,000 40.08 400,820
2011-12-15 CBST Option Ex 11,500 18.22 209,530
2011-12-15 CBST Sale 11,500 37.10 426,661
2009-03-30 CBST Option Ex 2,000 9.56 19,120
2008-07-22 CBST Sale 10,000 22.00 220,000
2008-07-22 CBST Option Ex 10,000 10.02 100,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rosenberg Martin (Director of Cubist Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.